New hope for diabetes-related vision loss?

NCT ID NCT05802329

First seen Dec 16, 2025 · Last updated May 10, 2026 · Updated 17 times

Summary

This early-stage study tests a new drug called OCU200 for people with diabetic macular edema, a condition that causes vision loss due to swelling in the retina. The main goal is to check safety, but researchers will also measure vision changes and eye pressure. About 24 adults with diabetes and vision loss will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Advanced Research LLC

    RECRUITING

    Deerfield Beach, Florida, 33064, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Email: •••••@•••••

    Contact

  • Erie Retina Research, LLC

    RECRUITING

    Erie, Pennsylvania, 16507, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Gundersen Health System

    RECRUITING

    La Crosse, Wisconsin, 54601, United States

    Contact Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Retina Consultants of America

    RECRUITING

    Southlake, Texas, 76092, United States

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Retina Consultants of Texas Research Centers

    RECRUITING

    Bellaire, Texas, 77401, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.